A Low Serum Calcium-to-Potassium Ratio Predicts Postpartum Venous Thromboembolism Risk: Mediation by Hemoglobin and D-Dimer in a Multicenter Cohort
Qian Li , Guofu Zhang , Xiating Li , Huafang Wang , Jun Deng , Zhipeng Cheng , Fengjuan Fan , Shi Chen , De Li , Liang V. Tang , Yu Hu
MedComm ›› 2026, Vol. 7 ›› Issue (7) : e70843
Postpartum venous thromboembolism (VTE) is a serious complication, and electrolytes may play a role in coagulation homeostasis, but their associations with postpartum VTE remain unclear. A total of 25,792 pregnant women from Chinese multicenter cohort between January 2017 and December 2024 were included, and the occurrences of postpartum VTE within 6 weeks after delivery were followed. Here, we show that dysregulated perinatal electrolyte profiles and a reduced serum calcium (Ca)/potassium (K) ratio are novel and independent risk factors for postpartum VTE, with hemoglobin and D-dimer levels mediating such associations. Restricted cubic spline analyses showed that low serum Ca (overall association p = 0.032) and high serum K (overall association p = 0.036) were associated with increased postpartum VTE risk. Serum magnesium exhibited a nonlinear inverse U-shaped association with VTE risk (nonlinear p = 0.021). Low serum Ca/K ratio was linked to elevated VTE risk (overall association p = 0.004), with a nonlinear relationship (nonlinear p = 0.042) and an inflection point at 0.55. Notably, a serum Ca/K ratio below 0.55 is a promising new biomarker for predicting the risk of postpartum VTE. Mediation analyses suggested that the protective effect of a higher Ca/K ratio might be partially explained by its association with higher hemoglobin levels (34.7% mediation, p = 0.036) and lower D-dimer levels (4.6% mediation, p = 0.018). This study suggests that strategies aimed at optimizing perinatal electrolyte balance and the monitoring and management of anemia may help reduce the burden of postpartum VTE.
electrolyte / hemoglobin / postpartum / pregnant women / venous thromboembolism
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
/
| 〈 |
|
〉 |